We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$130B
AUM Growth
+$12.3B
Cap. Flow
+$1.54B
Cap. Flow %
1.18%
Top 10 Hldgs %
17.24%
Holding
8,628
New
1,223
Increased
3,315
Reduced
2,707
Closed
1,164

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$548M
2
MU icon
Micron Technology
MU
+$461M
3
C icon
Citigroup
C
+$334M
4
AVGO icon
Broadcom
AVGO
+$319M
5
ABBV icon
AbbVie
ABBV
+$267M

Sector Composition

Rank Sector Weight
1 Technology 7.23%
2 Financials 5.58%
3 Industrials 4.98%
4 Consumer Discretionary 4.95%
5 Healthcare 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTR
3751
CALL
DELISTED
Frontier Communications Corp.
FTR
$1.35M ﹤0.01%
114,700
+102,887
+871% +$1.45M
SPHB icon
3752
Invesco S&P 500 High Beta ETF
SPHB
$957M
$1.35M ﹤0.01%
34,193
+5,206
+18% +$196K
CXSE icon
3753
WisdomTree Trust WisdomTree China ex-State-Owned Enterprises Fund
CXSE
$495M
$1.35M ﹤0.01%
+34,198
New +$1.26M
RMD icon
3754
PUT
ResMed
RMD
$32.4B
$1.35M ﹤0.01%
17,500
+6,000
+52% +$459K
SSYS icon
3755
CALL
Stratasys
SSYS
$781M
$1.35M ﹤0.01%
58,200
-21,300
-27% -$493K
AGQ icon
3756
ProShares Ultra Silver
AGQ
$1.43B
$1.34M ﹤0.01%
40,524
+10,801
+36% +$371K
RRGB icon
3757
CALL
Red Robin
RRGB
$192M
$1.34M ﹤0.01%
20,000
+8,900
+80% +$541K
JBL icon
3758
PUT
Jabil
JBL
$38B
$1.34M ﹤0.01%
46,900
+500
+1% +$15.1K
LBY
3759
DELISTED
Libbey, Inc.
LBY
$1.34M ﹤0.01%
144,587
-59,937
-29% -$491K
BSBR icon
3760
Santander
BSBR
$43.2B
$1.34M ﹤0.01%
159,733
-1,563,805
-91% -$12.8M
OSK icon
3761
CALL
Oshkosh
OSK
$9.44B
$1.34M ﹤0.01%
16,200
+9,200
+131% +$676K
RARE icon
3762
Ultragenyx Pharmaceutical
RARE
$2.61B
$1.34M ﹤0.01%
25,089
+20,746
+478% +$1.23M
ONCE
3763
PUT
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.34M ﹤0.01%
15,000
+11,100
+285% +$843K
LAMR icon
3764
PUT
Lamar Advertising Co
LAMR
$15.8B
$1.34M ﹤0.01%
19,500
+11,000
+129% +$744K
AMLP icon
3765
PUT
Alerian MLP ETF
AMLP
$13.2B
$1.33M ﹤0.01%
23,780
+2,440
+11% +$140K
CDNS icon
3766
PUT
Cadence Design Systems
CDNS
$89.5B
$1.33M ﹤0.01%
33,800
+19,800
+141% +$729K
ZTS icon
3767
PUT
Zoetis
ZTS
$30.5B
$1.33M ﹤0.01%
20,900
+5,900
+39% +$370K
LOGM
3768
PUT
DELISTED
LogMein, Inc.
LOGM
$1.33M ﹤0.01%
12,100
-5,000
-29% -$561K
BFX
3769
DELISTED
BowFlex Inc.
BFX
$1.33M ﹤0.01%
+78,668
New +$1.36M
TVTY
3770
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$1.33M ﹤0.01%
32,561
-43,497
-57% -$1.69M
MOAT icon
3771
VanEck Morningstar Wide Moat ETF
MOAT
$12.4B
$1.33M ﹤0.01%
+32,887
New +$1.3M
STE icon
3772
PUT
Steris
STE
$22.7B
$1.33M ﹤0.01%
15,000
-8,000
-35% -$678K
DLN icon
3773
WisdomTree US LargeCap Dividend Fund
DLN
$6.45B
$1.32M ﹤0.01%
30,456
+11,584
+61% +$494K
HDV
3774
iShares Core High Dividend ETF
HDV
$15.1B
$1.32M ﹤0.01%
76,915
+8,175
+12% +$138K
MKSI icon
3775
PUT
MKS Inc
MKSI
$21B
$1.32M ﹤0.01%
14,000
-3,300
-19% -$270K

Similar funds

Ken Griffin's Q3 2017 Portfolio in Review

As of Q3 2017, Ken Griffin held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Ken Griffin's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.

By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.4% a quarter earlier, followed by Financials and Industrials.

  • Ken Griffin's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
  • Ken Griffin added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
  • Ken Griffin's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
  • Ken Griffin fully exited Citigroup in Q3 2017, selling an estimated $334M.
  • Ken Griffin's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
  • Ken Griffin opened 1,223 new positions and closed 1,164 in Q3 2017.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $130B.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.